Palaniappan Jyoti 4
4 · Adaptive Biotechnologies Corp · Filed May 19, 2021
Insider Transaction Report
Form 4
Palaniappan Jyoti
SVP, Diagnostics, immunoSEQ Dx
Transactions
- Sale
Common Stock
2021-05-18$35.00/sh−651$22,785→ 9,158 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-18−651→ 106,996 totalExercise: $22.55Exp: 2030-03-19→ Common Stock (651 underlying) - Exercise/Conversion
Common Stock
2021-05-18$22.55/sh+651$14,680→ 9,809 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2020.
- [F2]The options vested with respect to 1/4 of such shares on March 18, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.